supp.fit

Curcumin: study protocols

290 study groups say how much Curcumin participants took a day. These are the doses the studies gave. They are not a recommendation.

Curcumin: what the research found →

Dose per serving from products

279 products in our catalogue print how much Curcumin a serving holds.

Most common: 100 mg to 250 mg, 23% of 279 products.

Dose per servingProducts
10 mg or less
12
10 mg to 25 mg
17
25 mg to 50 mg
63
50 mg to 100 mg
48
100 mg to 250 mg
65
250 mg to 500 mg
45
500 mg to 1 g
24
over 1 g
5

Dose per serving from research

289 study groups in 229 studies say how much Curcumin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 24% of 289 study groups.

Daily doseStudy groups
50 mg or less
9
50 mg to 100 mg
39
100 mg to 250 mg
68
250 mg to 500 mg
69
500 mg to 1 g
60
1 g to 2.5 g
28
2.5 g to 5 g
12
over 5 g
4

Commonly used together

67 of 290 study groups took Curcumin with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Piperine
30
Turmeric
6
Fish Oil
5
Boswellia
3
Docosahexaenoic Acid
3
Omega-3 Fatty Acids
3

290 study groups

Study
Curcumin Supplementation as a Preventive Strategy Against Tamoxifen-Induced Nonalcoholic Fatty Liver Disease in ER+ Breast Cancer Patients: A Triple-Blind Randomized Placebo-Controlled Trial
2025 · curcumin group · ER+ breast cancer patients scheduled to receive tamoxifen
500 mg26 weeks22
Curcumin extract for prevention of type 2 diabetes
2012 · curcumin-treated group · Adults aged 35 years or older with prediabetes
500 mg39 weeks—
Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial
2024 · curcuRouge (cR) group · Adults aged 20 years or older with asymptomatic or mild COVID-19
180 mg7 days71
Efficacy of Curcumin on Cognitive Function Scores in Women with Premenstrual Syndrome and Dysmenorrhea: A Triple-Blind, Placebo-Controlled Clinical Trial
2023 · curcumin group · Women with premenstrual syndrome and dysmenorrhea; age not stated
500 mg30 days62
The effect of curcumin on postpartum depression and anxiety in primiparous women: a double-blind randomized placebo-controlled clinical trial
2025 · Curcumin group · Primiparous women aged 18 years or older, within 12 hours after delivery, without a history of depression or other mental disorder and with EPDS score 12 or less
500 mg8 weeks48
Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study
2021 · curcumin · Adults aged 18–65, male and female, with self-reported gastrointestinal complaints and no diagnosed gastrointestinal disease
500 mg8 weeks39
Effect of Curcumin on Severity of Functional Dyspepsia: a Triple Blinded Clinical Trial
2021 · intervention group · Patients with functional dyspepsia according to Rome III criteria
500 mg30 days39
Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial
2025 · intervention group · Patients with migraine without aura
250 mg8 weeks35
Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial
2019 · Group A · Patients with oral submucous fibrosis; age and sex not stated
600 mg26 weeks30
Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial
2019 · curcumin group · Female adolescents aged 13–18 years with overweight or obesity
500 mg10 weeks30
Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
2020 · curcumin · Women aged 18–40 with polycystic ovary syndrome (PCOS)
500 mg12 weeks30
The effectiveness of phytosomal curcumin on clinical and laboratory parameters of patients with multiple trauma admitted to the intensive care unit: a double-blind randomized placebo-controlled trial
2024 · curcumin group · Adults aged 18–70 with moderate or severe multiple trauma admitted to the trauma ICU
500 mg7 days27
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial
2024 · NEC · Postmenopausal women with stage I–IIIa ER- and/or PR-positive breast cancer and aromatase inhibitor-induced arthropathy
200 mg90 days22
Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study
2020 · Theracurmin® · Patients with active mild-to-moderate Crohn's disease; age range and sex not reported
360 mg12 weeks20
The effectiveness of curcumin as a safe agent on hearing threshold improvement in patients with chronic kidney disease: a double-blind, placebo-controlled trial
2024 · curcumin group · Adults aged 18–50 with chronic kidney disease and hearing impairment
500 mg12 weeks20
A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study
2017 · 250 mg curcumin product group · Patients with active rheumatoid arthritis; age and sex not reported
500 mg90 days12
The dose-response effects of hydrolyzed curcumin on recovery, inflammation, and oxidative stress following exercise-induced muscle damage in males
2025 · LOW (single dose group) · Recreationally active males aged 18–41 years undergoing an exercise-induced muscle-damage protocol
750 mg7 days11
Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study
2017 · low-dose curcumin extract · People with major depressive disorder; age and sex not reported
500 mg12 weeks—
The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial
2018 · Curcuminoids nanomicelles plus mesalamine · Adults aged 18 years or older with mild to moderate ulcerative colitis
240 mg4 weeks—
Eight Weeks of a High Dose of Curcumin Supplementation May Attenuate Performance Decrements Following Muscle-Damaging Exercise
2019 · low dose of curcumin (50 mg of curcuminoids = 250 mg CurcuWIN®) · Men and women aged 19–29 years who were low to moderately trained and without stated musculoskeletal, medical, or metabolic contraindications to exercise
750 mg8 weeks—
Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study
2020 · curcumin group · Healthy men and women aged 50–85 years
400 mg12 weeks—
Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial
2021 · CGM (CurQfen) group · Adults with knee osteoarthritis
400 mg6 weeks—
Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial
2024 · curcumin-treated group (intervention) · Adults aged 35 years or older with obesity and type 2 diabetes diagnosed within the past 12 months; both sexes
500 mg1 year—
The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial
2024 · curcumin-treated (intervention) group · Adults aged 35 years or older with obesity and type 2 diabetes diagnosed within the previous year; sex not specified
500 mg1 year—
The effect of oral curcumin on vincristine-induced neuropathy in pediatric acute lymphoblastic leukemia: A double-blind randomized controlled clinical trial
2025 · curcumin-treatment group · Children aged 5–15 years with newly diagnosed acute lymphoblastic leukemia receiving vincristine
6 mg/kg90 days71
A clinical trial of curcumin effect in comparison to metronidazole on the treatment of bacterial vaginosis
2025 · intervention group (curcumin) · Women aged 18–49 with bacterial vaginosis; not pregnant or breastfeeding
80 mg7 days50
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial
2006 · curcumin · Patients with quiescent ulcerative colitis; age and sex not specified
2 g26 weeks45
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
2018 · nanocurcumin · Adults with definite or probable amyotrophic lateral sclerosis (ALS)
80 mg1 year27
Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial
2025 · Meriva · Adults with biopsy-proven nonalcoholic steatohepatitis (NASH); ages and sex not specified
2 g72 weeks26
Nano-curcumin supplementation in patients with mild and moderate acute pancreatitis: A randomized, placebo-controlled trial
2023 · nano-curcumin · Patients with mild or moderate acute pancreatitis
80 mg2 weeks21
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial
2019 · CUFOX (FOLFOX ± bevacizumab plus curcumin) · Adults with metastatic colorectal cancer awaiting first-line chemotherapy
2 g—18
Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study
2019 · curcumin group · Adults aged 38–65 years with symptomatic knee osteoarthritis and moderate knee pain
1.5 g4 weeks70
Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
2018 · CuraMed · Men and women aged 40–77 with degenerative hypertrophic knee osteoarthritis
1.5 g12 weeks66
An Investigation into the Effects of a Curcumin Extract (Curcugen(®)) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study
2021 · Curcumin extract · Adults aged 45–70, male and female, with diagnosed knee osteoarthritis and knee pain for at least 3 months
1 g8 weeks51
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial
2012 · curcumin · Male Iranian veterans aged 37–59 years with chronic pruritus after sulphur mustard exposure
1 g4 weeks46
Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial
2014 · bioavailability-boosted curcuminoids preparation · people with solid tumors receiving standard chemotherapy; age and sex not specified
180 mg8 weeks40
Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial
2023 · curcumin group · Adults aged 18–80 hospitalized with COVID-19
160 mg2 weeks37
Effect of curcumin supplementation on disease severity in patients with liver cirrhosis: A randomized controlled trial
2020 · curcumin group · Patients with liver cirrhosis aged 20–70 years
1 g90 days35
Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial
2020 · curcumin · Adults aged 20–70 years with liver cirrhosis; sex not specified
1 g12 weeks35
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study
2021 · BEC · Adults with mild-to-moderately active ulcerative colitis receiving standard-dose mesalamine
100 mg90 days34
Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study
2024 · TS-P1 group · healthy Japanese adults; age and sex not specified
150 mg12 weeks33
Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study
2024 · CR-033P group · healthy Japanese adults; age and sex not specified
150 mg12 weeks33
An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial
2015 · curcumin · Obese individuals; age range and sex not specified
1 g30 days30
A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial
2018 · Group B · Patients with clinically diagnosed oral submucous fibrosis; age and sex not reported
900 mg90 days30
Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease
2020 · curcumin group · Patients aged 45–85 years with type 2 diabetes mellitus and coronary heart disease
1 g12 weeks30
Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
2021 · nanocurcumin group · Inpatients with stable chronic schizophrenia and predominant negative symptoms; age and sex not specified
160 mg16 weeks28
Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial
2014 · combination group · Patients with major depressive disorder without concurrent suicidal ideation or other psychotic disorders; age and sex not reported
1 g6 weeks27
The nano-micellar curcumin improves International Prostate Symptoms Score (IPSS) in patients with benign prostatic hyperplasia: a randomized clinical trial
2023 · nano-micellar curcumin · Men with benign prostatic hyperplasia (BPH)
160 mg90 days26
Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial
2021 · Study group · Adults with cancer receiving chemotherapy, with or without head and neck radiotherapy, who were assessed before treatment and had no unrelated oral lesions
160 mg7 weeks25
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
2018 · bioavailable form of curcumin (Theracurmin) · Adults aged 51–84 years without dementia
180 mg548 days21
Evaluation of oral nano-curcumin formulation effectiveness in patients with mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind clinical trial
2026 · intervention · Patients with mild to moderate ulcerative colitis
160 mg30 days21
Recovery Of Bone And Muscle Mass In Patients With Chronic Kidney Disease And Iron Overload On Hemodialysis And Taking Combined Supplementation With Curcumin And Resveratrol
2019 · Group A (Resveratrol + Curcumin) · Adults with chronic kidney disease and iron overload undergoing hemodialysis; age and sex not restricted
500 mg12 weeks20
Role of oral bio-enhanced curcumin in dry eye disease
2025 · Group B: active drug supplement group · Adults aged 18 years or older with bilateral mild to moderate dry eye disease
1 g90 days20
Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial
2014 · curcuminoids · Patients with mild-to-moderate knee osteoarthritis; age and sex range not reported
1.5 g6 weeks19
Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study
2014 · Theracurmin · Adults over 40 years with radiographically confirmed primary medial knee osteoarthritis, Kellgren–Lawrence grade II or III
180 mg8 weeks18
Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial
2014 · curcumin group · Patients with major depressive disorder without concurrent suicidal ideation or other psychotic disorders; age and sex not reported
1 g6 weeks16
Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients
2013 · curcumin · Adults aged 18 or older with noninflammatory breast cancer or carcinoma in situ receiving radiotherapy without concurrent chemotherapy
1.5 g7 weeks14
A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study
2017 · 500 mg curcumin product group · Patients with active rheumatoid arthritis; age and sex not reported
1 g90 days12
The dose-response effects of hydrolyzed curcumin on recovery, inflammation, and oxidative stress following exercise-induced muscle damage in males
2025 · HIGH (double dose group) · Recreationally active males aged 18–41 years undergoing an exercise-induced muscle-damage protocol
1.5 g7 days12
Effects of oral curcumin ingested before or after eccentric exercise on markers of muscle damage and inflammation
2019 · Curcumin before exercise (Exp. 1) · Healthy men; age not reported
180 mg7 days10
Effects of oral curcumin ingested before or after eccentric exercise on markers of muscle damage and inflammation
2019 · Curcumin after exercise (Exp. 2) · Healthy men; age not reported
180 mg7 days10
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster)
2021 · lower-dose curcumin · Men aged 47–65 with Gulf War Illness
1 g30 days10
Effects of Curcumin C3 Complex® on Physical Function in Moderately Functioning Older Adults with Low-Grade Inflammation - A Pilot Trial
2023 · Curcumin C3 Complex® group · Adults aged 66–94 years with low-grade systemic inflammation and moderate physical functioning
1 g12 weeks9
Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study
2014 · curcumin · People with major depressive disorder; age and sex not specified
1 g8 weeks—
Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change
2015 · curcumin · Adults with major depressive disorder; age and sex not reported
1 g8 weeks—
Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2015 · curcumin · male adults aged 31–59 years with major depressive disorder receiving antidepressant medication
1 g6 weeks—
Safety, Tolerance, and Enhanced Efficacy of a Bioavailable Formulation of Curcumin With Fenugreek Dietary Fiber on Occupational Stress: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2016 · Standard curcumin · Adults experiencing occupational stress-related anxiety and fatigue; age range and sex not stated
1 g30 days—
Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults
2016 · curcumin treatment group · Community-dwelling older adults
1.5 g1 year—
Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study
2017 · high-dose curcumin extract · People with major depressive disorder; age and sex not reported
1 g12 weeks—
Effective Timing of Curcumin Ingestion to Attenuate Eccentric Exercise-Induced Muscle Soreness in Men
2019 · PRE · healthy young men
180 mg7 days—
Effective Timing of Curcumin Ingestion to Attenuate Eccentric Exercise-Induced Muscle Soreness in Men
2019 · POST · healthy young men
180 mg4 days—
The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis
2020 · curcumin · Patients with mild-to-moderate ulcerative colitis
1.5 g8 weeks—
Effects of fish oil and curcumin supplementation on cerebrovascular function in older adults: A randomized controlled trial
2020 · curcumin · Sedentary overweight/obese adults aged 50–80 years
160 mg16 weeks—
The effects of oral administration of curcumin-galactomannan complex on brain waves are consistent with brain penetration: a randomized, double-blinded, placebo-controlled pilot study
2022 · CGM · Healthy adults aged 35–65 years
1 g30 days—
The effects of oral administration of curcumin-galactomannan complex on brain waves are consistent with brain penetration: a randomized, double-blinded, placebo-controlled pilot study
2022 · Unformulated curcumin (UC) · Healthy adults aged 35–65 years
1 g30 days—
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients
2021 · nano-curcumin group · COVID-19 patients; age and sex not reported
160 mg2 weeks—
Efficacy of Curcuminoids in Managing Postoperative Pain after Total Laparoscopic Hysterectomy: A Randomized Controlled, Open-Label Trial
2022 · experimental group · Women who underwent laparoscopic hysterectomy
1 g3 days—
Promising clinical outcomes of nano-curcumin treatment as an adjunct therapy in hospitalized COVID-19 patients: A randomized, double-blinded, placebo-controlled trial
2023 · nano-curcumin group · Patients hospitalized with moderate-severe COVID-19; age and sex not specified
140 mg2 weeks—
Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial
2023 · curcumin plus omeprazole (C+O) · People with functional dyspepsia; age and sex distribution for this arm not reported
1 g4 weeks—
Curcumin plus piperine improve body composition in patients with inflammatory bowel disease: a randomized, double-blind, placebo-controlled clinical trial
2025 · curcumin · Adults aged 18 years or older with mild to moderate inflammatory bowel disease
1 g12 weeks—
Curcumin Supplementation Improves Gastrointestinal Symptoms in Women with Severe Obesity: A Double-Blind, Randomized, Placebo-Controlled Trial-A Pilot Study
2025 · curcuminoid group (CG) · Women aged 20–59 years with severe obesity (BMI ≥40 kg/m²), preparing for bariatric surgery
1.5 g13 weeks—
Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial
2019 · CC · People with hypercholesterolaemia; age and sex not reported
228 mg4 weeks—
Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial
2017 · IQP-CL-101 · Men and women aged 18–70 with irritable bowel syndrome meeting Rome III criteria and moderate-to-severe abdominal pain or discomfort
660 mg8 weeks43
Efficacy and Safety of Curcumin as an Adjuvant to Standard Chemotherapy in Advanced and Metastatic Breast Cancer Patients: A Randomized Controlled Study
2025 · chemotherapy with oral curcumin · Women with locally advanced or metastatic breast cancer
1 g24 weeks—
A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia
2016 · curcumin · People with oral leukoplakia
3.6 g26 weeks111
Add-on effect of curcumin to dienogest in patients with endometriosis: a randomized, double-blind, controlled trial
2025 · Curcumin and dienogest group · Women aged 18–45 with stage 2–3 pelvic endometriosis and moderate to severe pain
80 mg8 weeks43
Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial
2020 · nano-curcumin group · Patients with diabetes and diabetic polyneuropathy; age range and sex not reported
80 mg8 weeks40
The Effect of Nanocurcumin in Improvement of Knee Osteoarthritis: A Randomized Clinical Trial
2020 · nanocurcumin group · Patients with knee osteoarthritis; age and sex range not specified
80 mg6 weeks36
Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: A randomized clinical trial
2018 · intervention group · Infertile men; age range and specific infertility diagnosis not stated
80 mg10 weeks30
An Exploratory Analysis of Changes in Mental Wellbeing Following Curcumin and Fish Oil Supplementation in Middle-Aged and Older Adults
2020 · CUR group · Adults aged 50–80 years who were overweight or obese, sedentary, and without current major depression
960 mg16 weeks30
Nanocurcumin supplementation improves pulmonary function in severe COPD patients: A randomized, double blind, and placebo-controlled clinical trial
2024 · 80 mg nano-curcumin group · Patients with stage 3 or 4 severe COPD; age and sex not reported
80 mg90 days30
Comparison of oral Nano-Curcumin with oral prednisolone on oral lichen planus: a randomized double-blinded clinical trial
2020 · Group A (Curcumin) · Adults with erosive or atrophic oral lichen planus; age and sex ranges not specified
80 mg4 weeks29
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial
2015 · curcumin capsules · Patients with active mild-to-moderate ulcerative colitis who did not respond to additional maximum-dose oral and topical mesalamine therapy
3 g30 days26
Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress
2017 · Curcumin group · Healthy men and postmenopausal women aged 45–74 years with age-related conduit artery endothelial dysfunction
2 g12 weeks23
Comparative evaluation of novel nano-herbal and photo-biomodulation therapy for gingivitis in visually impaired children: A randomized controlled study
2025 · Group C · Visually impaired children aged 8–14 years with mild to moderate gingivitis
30 mg7 days20
Curcumin supplementation likely attenuates delayed onset muscle soreness (DOMS)
2015 · curcumin · men completing unaccustomed heavy eccentric exercise; age and health status not reported
5 g5 days17
Efficacy of Curcumin in Combination with Intralesional Dexamethasone with Hyaluronidase in the Treatment of Oral Submucous Fibrosis: A Randomized Controlled Trial
2022 · Group A (Test) · Adults aged 18 years and older with clinically diagnosed oral submucous fibrosis (OSF)
2 g6 weeks17
Significant immunomodulatory properties of curcumin in patients with osteoarthritis; a successful clinical trial in Iran
2020 · intervention · Patients with osteoarthritis selected according to American College of Rheumatology criteria
80 mg90 days15
Attenuation of indirect markers of eccentric exercise-induced muscle damage by curcumin
2015 · curcumin condition · Healthy, untrained men; mean age 23.5 years; no regular resistance training for at least 1 year
50 mg1 day14
The effect of curcumin and placebo on human gall-bladder function: an ultrasound study
1999 · curcumin · healthy volunteers, seven males and five females; age not reported
20 mg1 day12
Effect of different curcumin dosages on human gall bladder
2002 · 20 mg curcumin · 12 healthy volunteers; age and sex not specified
20 mg1 day12
Effect of different curcumin dosages on human gall bladder
2002 · 40 mg curcumin · 12 healthy volunteers; age and sex not specified
40 mg1 day12
Effect of different curcumin dosages on human gall bladder
2002 · 80 mg curcumin · 12 healthy volunteers; age and sex not specified
80 mg1 day12
Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial
2023 · curcumin capsule · Adults over 18 with radiotherapy-induced oral mucositis (grades 1–3) receiving head-and-neck radiotherapy; men and women
40 mg3 weeks12
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (Curcuma longa), Boswellia (Boswellia serrata), and French Maritime Pine Bark (Pinus pinaster)
2021 · higher-dose curcumin · Men aged 47–65 with Gulf War Illness
4 g30 days10
Effects of various food ingredients on gall bladder emptying
2013 · curcumin test product · healthy men and women aged 18–45
80 mg1 day8
High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus
2012 · curcuminoids group · Adults with oral lichen planus; age and sex not reported
6 g2 weeks—
Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels
2018 · Acitretin plus nanocurcumin · Patients with moderate-to-severe psoriasis (PASI > 10); age and sex not reported
3 g12 weeks—
Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
2019 · Curcumin · Patients with chronic schizophrenia; age and sex not reported
3 g24 weeks—
Eight Weeks of a High Dose of Curcumin Supplementation May Attenuate Performance Decrements Following Muscle-Damaging Exercise
2019 · high dose of curcumin (200 mg of curcuminoids = 1000 mg CurcuWIN®) · Men and women aged 19–29 years who were low to moderately trained and without stated musculoskeletal, medical, or metabolic contraindications to exercise
3 g8 weeks—
Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
2022 · treatment group · Patients with breast cancer receiving radiotherapy
80 mg——
Adjunctive curcumin nano-micelles reduce overall pruritus intensity in refractory post-burn pruritus: A randomized controlled trial
2025 · Standard treatment plus curcumin nano-micelle capsules · Adults with refractory post-burn pruritus
80 mg12 weeks—
An Exploratory Analysis of Changes in Mental Wellbeing Following Curcumin and Fish Oil Supplementation in Middle-Aged and Older Adults
2020 · FO + CUR group · Adults aged 50–80 years who were overweight or obese, sedentary, and without current major depression
960 mg16 weeks30
Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
2018 · Curamin · Men and women aged 40–77 with degenerative hypertrophic knee osteoarthritis
1.05 g12 weeks67
Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis
2022 · supplemented group · men and women aged 18–70 with irritable bowel syndrome, small bowel dysbiosis, and abdominal bloating
1 g30 days33
Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris
2015 · arm 1 · Adults with mild-to-moderate plaque psoriasis vulgaris (PASI < 10); sex and age range not specified
200 mg12 weeks31
The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial
2022 · curcumin-piperine group · Adults aged 18–65 with RT-PCR-confirmed COVID-19 who were outpatients and did not have severe disease requiring hospitalization
1 g2 weeks23
Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients
2024 · Group II · Female patients with systemic lupus erythematosus (SLE); age not reported
600 mg90 days15
Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients
2024 · Group III · Female patients with systemic lupus erythematosus (SLE); age not reported
600 mg90 days15
Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial
2025 · curcumin group · Adults over 50 years with hand osteoarthritis and hand pain or stiffness; mostly women
86.3 mg90 days13
Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study
2017 · combined low-dose curcumin extract plus saffron · People with major depressive disorder; age and sex not reported
500 mg12 weeks—
[Dry jelly concentrate with vitamins and dietary fiber in patients with IBS with constipation: a comparative controlled study]
2015 · Dry jelly concentrate group · Patients with IBS with constipation (IBS-C) meeting Rome III criteria; age and sex not reported
20 mg2 weeks—
Effects of fish oil and curcumin supplementation on cerebrovascular function in older adults: A randomized controlled trial
2020 · combination of fish oil and curcumin · Sedentary overweight/obese adults aged 50–80 years
160 mg16 weeks—
Curcumin plus piperine improve body composition in patients with inflammatory bowel disease: a randomized, double-blind, placebo-controlled clinical trial
2025 · curcumin plus piperine · Adults aged 18 years or older with mild to moderate inflammatory bowel disease
1 g12 weeks—
Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial
2014 · curcumin extract capsule · Patients with metabolic syndrome; age range and sex not specified
1.89 g12 weeks33
Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
2018 · Alendronate + curcumin · Postmenopausal women aged 55–65 with osteoporosis
110 mg1 year20
Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial
2025 · curcumin group · Adults aged 60 years and older with prediabetes and/or BMI ≥25 kg/m²; no preexisting diabetes
80 mg12 weeks17
Comparative Pharmacokinetic of Curcuminoids Formulations with an Omega-3 Fatty Acids Monoglyceride Carrier: A Randomized Cross-Over Triple-Blind Study
2022 · Curcuminoids extract in powder · Healthy males and females aged 18–50 years
200 mg1 day31
The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
2014 · Native powder · Healthy women and men; women and men aged not reported
500 mg1 day23
The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
2014 · Micronized powder · Healthy women and men; women and men aged not reported
500 mg1 day23
The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
2014 · Liquid micelles · Healthy women and men; women and men aged not reported
500 mg1 day23
Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study
2017 · Volatile oil formulation · Healthy adult men
500 mg1 day15
Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study
2017 · Phospholipid formulation · Healthy adult men
500 mg1 day15
A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-Blind, Crossover Study
2018 · Unformulated 95% curcumin powder in capsule form · 12 healthy adult subjects
323 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Native curcumin · 12 healthy adults
207 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Liposome curcumin · 12 healthy adults
207 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Submicron-particle curcumin · 12 healthy adults
207 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Curcumin phytosomes · 12 healthy adults
207 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Curcumin-γ-cyclodextrin complex · 12 healthy adults
207 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Micellar curcumin · 12 healthy adults
207 mg1 day12
Oil-Based Curcuminoid Phospholipid Formulation Mimicking Natural Digestion Enhances Oral Bioavailability of Curcuminoids in Healthy Subjects
2024 · Oil/PL-based formulation · 12 healthy subjects; age range and sex not reported
200 mg1 day12
Oil-Based Curcuminoid Phospholipid Formulation Mimicking Natural Digestion Enhances Oral Bioavailability of Curcuminoids in Healthy Subjects
2024 · Pure curcuminoids extract (reference product) · 12 healthy subjects; age range and sex not reported
200 mg1 day12
Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)
2019 · Curcumin with LipiSperse® · Healthy male and female volunteers; ages not reported
750 mg1 day—
Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)
2019 · Raw curcumin product · Healthy male and female volunteers; ages not reported
750 mg1 day—
Food matrix and co-presence of turmeric compounds influence bioavailability of curcumin in healthy humans
2019 · curcumin powder meal · healthy male participants; age not reported
400 mg1 day—
Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study
2021 · STE95 · 14 subjects; age, sex and health status not specified
500 mg1 day—
Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
2022 · Treatment group · Children aged 6–17 years with obesity (BMI above the 95th percentile for age)
100 mg26 weeks16
Supplementation with Whey Protein, Omega-3 Fatty Acids and Polyphenols Combined with Electrical Muscle Stimulation Increases Muscle Strength in Elderly Adults with Limited Mobility: A Randomized Controlled Trial
2020 · WPI + BIO · Adults aged 60–90 with mobility limitations and gait speed below 1.5 m/s
500 mg12 weeks10
Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial
2024 · Curcumin-treated group · Adults aged 35 years or older with obesity and recently diagnosed, well-controlled type 2 diabetes
500 mg1 year114
Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial
2013 · curcuminoids · Overweight or obese adults with type 2 diabetes
300 mg90 days50
Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial
2021 · curcuminoid group · Adults aged 20 years or older with stage-3 colorectal cancer who had surgery and were undergoing chemotherapy
500 mg8 weeks36
Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial
2019 · curcumin group · Female adolescents aged 13–18 years with overweight or obesity
500 mg10 weeks30
The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study
2016 · CUR 320 mg/day, diabetic proteinuric CKD · Adults aged 20–70 with diabetic proteinuric chronic kidney disease
320 mg8 weeks28
The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
2023 · curcumin group · Women aged 18–45 with PCOS and BMI 18.5–40
500 mg12 weeks27
The Effect of Dietary Supplementation With Curcumin on Redox Status and Nrf2 Activation in Patients With Nondiabetic or Diabetic Proteinuric Chronic Kidney Disease: A Pilot Study
2016 · CUR 320 mg/day, nondiabetic proteinuric CKD · Adults aged 20–70 with nondiabetic proteinuric chronic kidney disease
320 mg8 weeks24
A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study
2018 · CGM group · Men aged 30–50 with chronic alcohol use and elevated liver function markers, without diagnosed liver disease
500 mg8 weeks24
Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
2021 · curcumin group · Patients with non-alcoholic fatty liver disease; age and sex not specified
250 mg8 weeks22
Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial
2022 · CP group (curcumin plus placebo) · Adults aged 18 years or older with metabolic syndrome; men and women
200 mg12 weeks22
Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial
2018 · curcumin (CC) · Hypercholesterolaemic individuals; age range and sex not reported
200 mg4 weeks18
Curcumin supplementation reduces blood glucose and serum lipids of Brazilian women with high waist circumference: a randomized clinical trial
2022 · Supplemented group (SG) · Adult and elderly Brazilian women aged 20 years or older with high waist circumference (≥80 cm)
500 mg90 days15
Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers
2007 · Curcumin with talinolol · 12 healthy Chinese volunteers
300 mg7 days12
Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study
2008 · NCB-02 · Patients with type 2 diabetes mellitus
300 mg8 weeks—
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
2019 · phospholipid curcumin group · Adults with non-alcoholic fatty liver disease (NAFLD); age range and sex not reported
250 mg8 weeks—
Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: A randomized placebo-controlled clinical trial
2019 · intervention group · overweight and obese postpubescent adolescent girls
500 mg10 weeks—
The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial
2019 · curcumin group · Women with polycystic ovary syndrome who were overweight or obese; age range not reported
500 mg6 weeks—
Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial
2021 · curcumin group · Patients undergoing elective coronary angioplasty; age and sex not specified
500 mg8 weeks—
The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2021 · active intervention group · Adults with metabolic syndrome
500 mg12 weeks—
The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
2021 · curcumin group · Patients with non-alcoholic fatty liver disease; age and sex not specified
250 mg60 days—
Effects of curcumin supplementation on metabolic parameters, inflammatory factors and obesity values in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial
2022 · curcumin · Women with rheumatoid arthritis
500 mg8 weeks—
The efficacy of curcumin supplementation on serum total antioxidant capacity, malondialdehyde, and disease activity in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial
2024 · curcumin · women with rheumatoid arthritis
500 mg8 weeks—
Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial
2024 · curcumin · Patients with nonalcoholic simple fatty liver (NASFL); age and sex not reported
500 mg24 weeks—
Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial
2024 · curcumin-treated group (intervention) · Adults aged 35 years or older with obesity and type 2 diabetes diagnosed within the past 12 months; both sexes
500 mg1 year—
Effects of metformin and curcumin in women with polycystic ovary syndrome: A factorial clinical trial
2024 · nanocurcumin + placebo · Women with polycystic ovary syndrome; age range not reported
240 mg12 weeks—
Effects of metformin and curcumin in women with polycystic ovary syndrome: A factorial clinical trial
2024 · metformin + nanocurcumin · Women with polycystic ovary syndrome; age range not reported
240 mg12 weeks—
Curcumin for Inflammation Control in Individuals with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial
2025 · curcumin group · Adults aged 35 years or older with type 2 diabetes mellitus and FibroScan-confirmed MASLD
500 mg1 year—
Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
2025 · curcumin group · Adults aged 35 years or older with obesity and type 2 diabetes, using metformin for glycemic control
500 mg1 year—
Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial
2019 · PS-CC · People with hypercholesterolaemia; age and sex not reported
228 mg4 weeks—
Comparative Pharmacokinetic of Curcuminoids Formulations with an Omega-3 Fatty Acids Monoglyceride Carrier: A Randomized Cross-Over Triple-Blind Study
2022 · Curcuminoids extract combined with rice oil · Healthy males and females aged 18–50 years
200 mg1 day31
The Effect of Curcumin on Serum Copper and Zinc and Zn/Cu Ratio in Individuals with Metabolic Syndrome: A Double-Blind Clinical Trial
2019 · curcumin · Individuals with metabolic syndrome
1 g6 weeks—
The Effect of Curcumin on Serum Copper and Zinc and Zn/Cu Ratio in Individuals with Metabolic Syndrome: A Double-Blind Clinical Trial
2019 · phospholipidated curcumin · Individuals with metabolic syndrome
1 g6 weeks—
Comparative bioavailability of curcuminoids from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over, comparative, pharmacokinetic study
2021 · WDTE60N · 14 subjects; age, sex and health status not specified
150 mg1 day—
Effects of supplementation with curcumin on serum adipokine concentrations: A randomized controlled trial
2016 · curcumin · Patients with metabolic syndrome
1 g8 weeks59
Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial
2016 · curcumin · Males and females with metabolic syndrome; age range not reported
1 g8 weeks59
Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
2016 · curcumin · Patients with nonalcoholic fatty liver disease, grades 1–3
1 g8 weeks50
Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
2017 · curcumin group · Patients diagnosed with NAFLD grades 1–3
1 g8 weeks50
A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications
2012 · curcumin · Male Iranian veterans aged 37–59 with chronic sulphur mustard-induced pruritic skin lesions
1 g4 weeks46
The Combined Effects of an Anti-Inflammatory Diet and Curcumin Supplementation on Thyroid Function and Lipid Profile in Patients With Hashimoto's Thyroiditis: A Double Blind Randomised Clinical Trial
2026 · curcumin group · Adults aged 20–70 with Hashimoto's thyroiditis; 89.3% female in the analysed group
1.32 g12 weeks31
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial
2013 · curcuminoids · Obese individuals with dyslipidemia; age range and sex not specified
1 g30 days30
Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals
2013 · curcuminoids · 30 obese individuals
1 g30 days30
Nanomicelle curcumin improves oxidative stress, inflammatory markers, and assisted reproductive techniques outcomes in endometriosis cases: a randomized clinical trial
2025 · intervention group · Women aged 25–35 with stage III/IV endometriosis who were candidates for assisted reproductive techniques
120 mg10 weeks25
Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial
2022 · nanocurcumin group · COVID-19 patients; age range and sex not stated
160 mg6 days24
Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD
2016 · Theracurmin group · Men and women aged 20–85 with stage I or II COPD
180 mg26 weeks22
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
2020 · Nano-curcumin group · Adults aged 19–69 with confirmed COVID-19 in the ARDS phase
160 mg2 weeks20
Effects of curcumin on the pharmacokinetics of talinolol in human with ABCB1 polymorphism
2012 · Curcumin-treated phase · Healthy male volunteers with different ABCB1 C3435T genotypes
1 g2 weeks18
Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK-9 Concentrations in Healthy Subjects in a Double-Blind, Randomized, Active-Controlled, Crossover Trial
2022 · Micellar curcumin · Healthy volunteers aged 18–60 years, men and women
129 mg7 days16
Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK-9 Concentrations in Healthy Subjects in a Double-Blind, Randomized, Active-Controlled, Crossover Trial
2022 · Native curcumin · Healthy volunteers aged 18–60 years, men and women
129 mg7 days16
Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial
2019 · CC (curcumin) · Adults aged 30–70 at high risk of type 2 diabetes or with impaired fasting glucose or impaired glucose tolerance; men and women
180 mg12 weeks15
Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
2019 · Theracurmin® · Men and women aged 20–85 with impaired glucose tolerance or non-insulin-dependent diabetes mellitus
180 mg26 weeks15
Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial
2023 · CURC · Healthy adults aged 18–65 who had recovered from asymptomatic, mild, or moderate COVID-19 and subsequently received a primary series of COVID-19 vaccine doses
1 g4 weeks15
Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer's Disease
2020 · curcumin group · Adults aged 30–70 with overweight or obesity and impaired fasting glucose and/or impaired glucose tolerance, at high risk of type 2 diabetes
180 mg12 weeks14
Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study
2012 · exercise training with curcumin ingestion · postmenopausal women
150 mg8 weeks12
Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study
2012 · curcumin ingestion · postmenopausal women
150 mg8 weeks11
Effects of curcumin supplementation on exercise-induced oxidative stress in humans
2014 · double (before and immediately after exercise) · Men, mean age 26.8 years, completing treadmill exercise
180 mg1 day10
Benefits of Curcumin Supplementation on Antioxidant Status in β-Thalassemia Major Patients: A Double-Blind Randomized Controlled Clinical Trial
2017 · curcumin group · Patients with β-thalassemia major
1 g12 weeks—
The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
2019 · curcumin · Patients with non-alcoholic fatty liver disease
1.5 g12 weeks—
The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
2019 · curcumin group · patients with type 2 diabetes
1.5 g10 weeks—
Effect of Curcumin Supplementation on Exercise-Induced Oxidative Stress, Inflammation, Muscle Damage, and Muscle Soreness
2020 · curcumin group · males; age and health condition not specified
1.5 g4 weeks—
Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity
2020 · curcumin · Adults aged 50–80 years with overweight or obesity (BMI 25–40 kg/m²)
160 mg16 weeks—
Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial
2021 · curcumin group · Individuals with polycystic ovary syndrome (age and sex not specified)
1.5 g12 weeks—
Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial
2021 · curcumin group · Hemodialysis patients; age range and sex not specified
1 g12 weeks—
Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study
2022 · FS18_Curc (ferrous sulphate—18 mg elemental iron + 500 mg curcumin) · Generally healthy adults aged 18–40 years with ferritin in the normal range; men and women
500 mg6 weeks—
Curcumin and vitamin E improve hot flashes, lipid profile, and fasting blood glucose without any detrimental effect on the liver and renal function in postmenopausal women: A triple-blind placebo-controlled clinical trial
2024 · Curcumin group · Postmenopausal women
1 g8 weeks—
Therapeutic Potential of Curcumin with and without Strengthening Exercises in Improving Rheumatoid Arthritis
2022 · Group A · Patients with rheumatoid arthritis; age and sex not reported
180 mg24 weeks—
Therapeutic Potential of Curcumin with and without Strengthening Exercises in Improving Rheumatoid Arthritis
2022 · Group B · Patients with rheumatoid arthritis; age and sex not reported
180 mg24 weeks—
The effects of curcumin supplementation on inflammatory markers in systemic lupus erythematosus patients: a randomized placebo-controlled trial
2024 · Curcumin group · Adults aged 18–60 with systemic lupus erythematosus (SLE)
1 g10 weeks—
Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects
2021 · CR-033P · Healthy men aged 19–60 years
90 mg1 day24
Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects
2021 · CR-031P · Healthy men aged 19–60 years
30 mg1 day24
Comparative pharmacokinetics of Theracurmin, a highly bioavailable curcumin, in healthy adult subjects
2021 · Unformulated curcumin powder · Healthy men aged 19–60 years
90 mg1 day24
Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers
2017 · standard curcumin extract · Healthy male and female volunteers aged 18–65 years
2.92 g7 days16
A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-Blind, Crossover Study
2018 · CLDM (curcumin liquid droplet micromicellar formulation) · 12 healthy adult subjects
64.6 mg1 day12
Urine and serum analysis of consumed curcuminoids using an IkappaB-luciferase surrogate marker assay
2010 · curcuminoid test group · Men and women aged 18 years or older with normal organ function
8 g1 day10
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects
2008 · 10 g dose · Healthy adults aged 18–65 years, all Caucasian, with normal organ function
10 g1 day6
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects
2008 · 12 g dose · Healthy adults aged 18–65 years, all Caucasian, with normal organ function
12 g1 day6
Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial
2021 · Group 2 · Women with polycystic ovary syndrome diagnosed according to the Rotterdam criteria
80 mg90 days50
The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial
2020 · curcumin · Patients with polycystic ovarian syndrome (PCOS); age and sex details not stated
4.5 g90 days36
Acute Administration of Bioavailable Curcumin Alongside Ferrous Sulphate Supplements Does Not Impair Iron Absorption in Healthy Adults in a Randomised Trial
2021 · FS18_Curc (ferrous sulphate–18 mg elemental iron + 500 mg curcumin) · Healthy adults aged 18–40 years with ferritin in the normal UK range
500 mg1 day31
Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial
2014 · Curcuminoids · Adults aged 18–65 with obesity (BMI ≥30) and specified coronary heart disease risk factors and LDL-C levels
1 g30 days30
The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial
2020 · nano-curcumin group · Patients with diabetes on hemodialysis
80 mg12 weeks30
The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial
2021 · nanocurcumin group · patients with grade 3 diabetic foot ulcer; age and sex not reported
80 mg12 weeks30
Effect of nano-curcumin supplementation on liver fibrosis in patients with NAFLD-associated fibrosis: a double-blind randomized controlled trial
2025 · nano-curcumin group · Adults aged 30–70 with NAFLD-associated liver fibrosis, stage F2 or higher; men and women
80 mg16 weeks27
The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker
2009 · Curcumin · Patients with monoclonal gammopathy of undetermined significance (MGUS)
4 g—26
Impaired postprandial GLP-2 response enhances endotoxemia, systemic inflammation, and kidney injury in metabolic dysfunction-associated steatohepatitis (MASH): effect of phospholipid curcumin meriva
2024 · Meriva (phospholipid curcumin) · Adults with biopsy-proven MASH, with or without chronic kidney disease; ages approximately 53–56 years
2 g72 weeks26
The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial
2021 · nano-curcumin group · Patients with metabolic syndrome; age and sex not specified
80 mg12 weeks25
The effects of nano-curcumin supplementation on adipokines levels in obese and overweight patients with migraine: a double blind clinical trial study
2022 · nano-curcumin group · Adults aged 20–50 with BMI 25–35 and episodic migraine; 42 women and 2 men enrolled overall
80 mg60 days22
Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial
2022 · CQ group (curcumin plus coenzyme Q10) · Adults aged 18 years or older with metabolic syndrome; men and women
200 mg12 weeks22
Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial
2024 · nano-curcumin · Overweight or obese adults aged 35–70 with coronary slow flow phenomenon
80 mg12 weeks21
Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study
2016 · curcumin group (CG) · Patients with prostate cancer undergoing radiotherapy; age and sex not stated
3 g—20
Analysis of Curcumin as a Radiosensitizer in Cancer Therapy with Serum Survivin Examination: Randomised Control Trial
2021 · Curcumin + radiation · Women with stage IIB–IIIB cervical carcinoma receiving radiotherapy
4 g7 days20
Effect of adding fenofibrate versus curcumin to glimepiride in patients with type 2 diabetes: a randomized controlled trial
2025 · Curcumin group · Adults aged 35–70 with uncontrolled type 2 diabetes treated with glimepiride
1.1 g12 weeks20
Nanocurcumin supplementation ameliorates Behcet's disease by modulating regulatory T cells: A randomized, double-blind, placebo-controlled trial
2021 · nanocurcumin group · Adults with Behçet's disease
80 mg8 weeks17
Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study
2018 · curcumin (CC) · Healthy men and women aged 18–45 years with BMI below 30 kg/m²
90 mg1 day15
Effects of curcumin supplementation on exercise-induced oxidative stress in humans
2014 · single (only before exercise) · Men, mean age 26.8 years, completing treadmill exercise
90 mg1 day10
Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
2016 · curcumin group · Patients with ultrasonographic evidence of non-alcoholic fatty liver disease
70 mg8 weeks—
An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in β-thalassemia major patients: A double-blind randomized controlled clinical trial
2018 · Curcumin group · Patients with β-thalassemia major; age and sex not specified
2 g12 weeks—
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study
2018 · Nanocurcumin group · Patients with episodic migraine
80 mg60 days—
Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial
2021 · nano-curcumin group · Patients undergoing elective coronary angioplasty; age and sex not specified
80 mg8 weeks—
Three months of combination therapy with nano-curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double-blinded, placebo-controlled clinical trial
2023 · nano-curcumin · Patients with type 2 diabetes and mild to moderate coronary artery disease; age and sex not stated
80 mg90 days—
"The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial"
2025 · curcumin group · Breast cancer patients receiving doxorubicin chemotherapy; age and sex details not reported
80 mg26 weeks—
Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial
2016 · curcuminoids + piperine combination · Adults with chronic pulmonary complications due to sulfur mustard exposure
1.5 g4 weeks45
Effects of curcumin supplementation on vitamin D levels in women with premenstrual syndrome and dysmenorrhea: a randomized controlled study
2022 · CUR group · Single women aged 18–24 with moderate to severe premenstrual syndrome and dysmenorrhea
500 mg90 days38
Comparative Pharmacokinetic of Curcuminoids Formulations with an Omega-3 Fatty Acids Monoglyceride Carrier: A Randomized Cross-Over Triple-Blind Study
2022 · Curcuminoids extract emulsified in MAG-OM3 oil · Healthy males and females aged 18–50 years
200 mg1 day31
Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers
2017 · curcumin phosphatidylcholine extract · Healthy male and female volunteers aged 18–65 years
385 mg7 days16
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Curcumin with turmeric oils · 12 healthy adults
207 mg1 day12
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments
2021 · Curcumin with adjuvants, including piperine · 12 healthy adults
207 mg1 day12
Food matrix and co-presence of turmeric compounds influence bioavailability of curcumin in healthy humans
2019 · turmeric powder meal · healthy male participants; age not reported
400 mg1 day—
Food matrix and co-presence of turmeric compounds influence bioavailability of curcumin in healthy humans
2019 · grated fresh turmeric root meal · healthy male participants; age not reported
400 mg1 day—
Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis
2015 · curcuminoids · Adults with metabolic syndrome diagnosed according to NCEP-ATPIII criteria
1 g8 weeks59
Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial
2014 · curcuminoids · Patients diagnosed with metabolic syndrome according to NCEP-ATPIII criteria and receiving standard of care
1 g8 weeks50
Curcuminoids Plus Piperine Modulate Adipokines in Type 2 Diabetes Mellitus
2017 · curcuminoids versus placebo group · Patients with type 2 diabetes; age and sex not reported
1 g12 weeks50
Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial
2018 · curcuminoids · Adults aged 18–65 with type 2 diabetes mellitus
500 mg90 days50
Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial
2022 · curcumin · Young women with premenstrual syndrome and primary dysmenorrhea
500 mg—40
The Effects of Curcumin Plus Piperine Supplementation in Patients with Acute Myocardial Infarction: A Randomized, Double-Blind, and Placebo-Controlled Trial
2021 · active intervention group · Patients aged 18–75 years with acute myocardial infarction
500 mg8 weeks38
Effect of curcumin on inflammatory biomarkers and iron profile in patients with premenstrual syndrome and dysmenorrhea: A randomized controlled trial
2023 · Curcumin (CUR) group · Women aged 18–24 with moderate-to-severe premenstrual syndrome and dysmenorrhea
500 mg—38
The effects of curcumin-piperine supplementation on inflammatory, oxidative stress and metabolic indices in patients with ischemic stroke in the rehabilitation phase: a randomized controlled trial
2023 · curcumin-piperine group · Adults aged 20–65 years with ischemic stroke in the rehabilitation phase, 3–6 months after the active stroke attack
500 mg12 weeks33
Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: a randomized double-blind controlled trial
2025 · intervention group (curcumin-piperine) · Adults aged 20–75 with sepsis admitted to an ICU
1 g7 days33
Acute Administration of Bioavailable Curcumin Alongside Ferrous Sulphate Supplements Does Not Impair Iron Absorption in Healthy Adults in a Randomised Trial
2021 · FS65_Curc (ferrous sulphate–65 mg elemental iron + 500 mg curcumin) · Healthy adults aged 18–40 years with ferritin in the normal UK range
500 mg1 day31
Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial
2023 · curcumin + piperine · Patients with moderate-to-high non-alcoholic fatty liver disease diagnosed by liver sonography; age and sex not specified
500 mg12 weeks30
Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes
2016 · Group 2 (curcumin/BSE group; MD plus Fitomuscle®) · Healthy male master cyclists, mean age 46 ± 8 years, without the listed cardiovascular, metabolic or chronic inflammatory conditions
10 mg12 weeks25
Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study
2011 · trial group · Patients with overt type 2 diabetic nephropathy; age and sex not specified
66.3 mg60 days20
Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial
2016 · curcuminoids group · Adults with mild-to-moderate primary knee osteoarthritis
1.5 g6 weeks19
Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial
2018 · combination of phytosterols and curcumin (PS-CC) · Hypercholesterolaemic individuals; age range and sex not reported
200 mg4 weeks17
Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial
2019 · CC-FO (curcumin plus fish oil) · Adults aged 30–70 at high risk of type 2 diabetes or with impaired fasting glucose or impaired glucose tolerance; men and women
180 mg12 weeks16
Bioactive Yoghurt Containing Curcumin and Chlorogenic Acid Reduces Inflammation in Postmenopausal Women
2022 · bioactive yoghurt · Women aged 45–65, overweight or obese (BMI 25–40), postmenopausal for at least one year
103 mg1 day16
Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study
2012 · trial group · Patients with relapsing or refractory biopsy-proven lupus nephritis
66.3 mg90 days12
Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial
2017 · curcuminoids · People with type 2 diabetes
1 g12 weeks—
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study
2018 · Combination of ω-3 fatty acids plus nano-curcumin · Patients with episodic migraine
80 mg60 days—
Influence of enhanced bioavailable curcumin on obesity-associated cardiovascular disease risk factors and arterial function: A double-blinded, randomized, controlled trial
2019 · curcumin intervention group · Men aged 18–35 years with obesity (BMI ≥30.0 kg/m²)
500 mg12 weeks—
Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial
2019 · curcuminoids plus piperine · Adults with ultrasound-determined nonalcoholic fatty liver disease; age and sex not specified
500 mg12 weeks—
Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial
2020 · curcuminoids group · Patients with non-alcoholic fatty liver disease (NAFLD); age and sex not reported
500 mg8 weeks—
Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial
2020 · Curcuminoids · Critically ill patients aged 18–65 years with traumatic brain injury
500 mg7 days—
Ubiquitin Proteasome System Activity is Suppressed by Curcumin following Exercise-Induced Muscle Damage in Human Skeletal Muscle
2021 · curcumin (CUR) group · Recreationally active males and females aged 18–30
2 g11 days—
Co-Administration of Iron and Bioavailable Curcumin Reduces Levels of Systemic Markers of Inflammation and Oxidative Stress in a Placebo-Controlled Randomised Study
2022 · FS65_Curc (ferrous sulphate—65 mg elemental iron + 500 mg curcumin) · Generally healthy adults aged 18–40 years with ferritin in the normal range; men and women
500 mg6 weeks—
Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial
2023 · curcumin-piperine · Patients with COVID-19 admitted to the intensive care unit; age and sex not specified
1.5 g7 days—
Evaluation of the effectiveness of curcumin and piperine co-supplementation on inflammatory factors, cardiac biomarkers, atrial fibrillation, and clinical outcomes after coronary artery bypass graft surgery
2024 · Group B · Adults who underwent coronary artery bypass graft surgery
500 mg5 days—
Evaluation of the effectiveness of curcumin and piperine co-supplementation on inflammatory factors, cardiac biomarkers, atrial fibrillation, and clinical outcomes after coronary artery bypass graft surgery
2024 · Group C · Adults who underwent coronary artery bypass graft surgery
1 g5 days—
Evaluation of the effectiveness of curcumin and piperine co-supplementation on inflammatory factors, cardiac biomarkers, atrial fibrillation, and clinical outcomes after coronary artery bypass graft surgery
2024 · Group D · Adults who underwent coronary artery bypass graft surgery
1.5 g5 days—
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
2022 · Nutraceutical (Livogen Plus®) · Adults aged 30–75 with hepatic steatosis (NAFLD), without diabetes
667 mg12 weeks70
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
2020 · Phytosomal curcumin · Adults aged 18–70 years with overweight (BMI 25–30 kg/m²) and suboptimal fasting plasma glucose (100–125 mg/dL)
200 mg8 weeks40
Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial
2021 · curcumin group · Adults aged 18–65 with non-alcoholic fatty liver disease diagnosed by liver sonography
500 mg60 days39
Evaluation of Cognitive Performance following Fish-Oil and Curcumin Supplementation in Middle-Aged and Older Adults with Overweight or Obesity
2020 · combination · Adults aged 50–80 years with overweight or obesity (BMI 25–40 kg/m²)
160 mg16 weeks—